These results demonstrate that ob/ob mice under the FFD regime develop hallmarks of human NASH, such as obesity, hyperinsulinemia, elevated ALT levels, steatohepatitis and fibrosis. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.